Mikkel R. Simonsen

Aalborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Clinical outcomes of patients with diffuse large B-cell lymphoma and concomitant rheumatoid arthritis: a nationwide Danish register-based cohort study.

Clinical outcomes of patients with diffuse large B-cell lymphoma and concomitant rheumatoid arthritis: a nationwide Danish register-based cohort study.

Journal: EULAR rheumatology open

Published: June 29, 2026

Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single-Arm Trials: Insights from Aggressive Lymphoma.

Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single-Arm Trials: Insights from Aggressive Lymphoma.

Journal: Clinical pharmacology and therapeutics

Published: March 30, 2026

First-line immunochemotherapy for indolent lymphoma does not affect muscle volume: a post hoc analysis of 472 patients in long-term remissions from the GALLIUM study.

First-line immunochemotherapy for indolent lymphoma does not affect muscle volume: a post hoc analysis of 472 patients in long-term remissions from the GALLIUM study.

Journal: Leukemia & lymphoma

Published: March 25, 2026

Population-based survival after mantle cell lymphoma in Norway and Denmark: Limited impact of earlier BTKi access.

Population-based survival after mantle cell lymphoma in Norway and Denmark: Limited impact of earlier BTKi access.

Journal: British journal of haematology

Published: February 27, 2026

Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population-Based Study of Patients With B-Cell Malignancies.

Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population-Based Study of Patients With B-Cell Malignancies.

Journal: European journal of haematology

Published: February 03, 2026

Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification.

Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification.

Journal: British journal of haematology

Published: January 14, 2026

Machine Learning for Prediction of High-Risk Infections in Patients With Cancer.

Machine Learning for Prediction of High-Risk Infections in Patients With Cancer.

Journal: Cancer medicine

Published: December 18, 2025

Older patients with lymphoma: navigating a landscape of clinical controversies and barriers to innovation.

Older patients with lymphoma: navigating a landscape of clinical controversies and barriers to innovation.

Journal: Haematologica

Published: August 27, 2025

Opportunities and risks associated with external comparator cohorts in clinical drug development in hematology.

Opportunities and risks associated with external comparator cohorts in clinical drug development in hematology.

Journal: Blood cancer journal

Published: August 24, 2025

A-calibration: assessment of prediction models for survival data under censoring.

A-calibration: assessment of prediction models for survival data under censoring.

Journal: BMC medical research methodology

Published: May 26, 2025

Machine Learning for Prediction of High-Risk Hospitalizations in Lymphoma Patients: A Danish Population-Based Study.

Machine Learning for Prediction of High-Risk Hospitalizations in Lymphoma Patients: A Danish Population-Based Study.

Journal: European journal of haematology

Published: April 02, 2025

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study.

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study.

Journal: Blood neoplasia

Published: February 25, 2025

Showing 1-12 of 24

Last Updated: 09/26/2026